HK Stock MarketDetailed Quotes

09989 HEPALINK

Watchlist
  • 2.780
  • +0.090+3.35%
Market Closed Mar 28 16:08 CST
4.08BMarket Cap17.16P/E (TTM)

About HEPALINK Company

The company was founded in 1998 in Shenzhen, China. “Bringing the gospel to patients is our mission and becoming a leading international pharmaceutical company” was the founder's intention. Continued and unremitting efforts have enabled Hyperion to establish an integrated safe supply chain, becoming the world's largest heparin sodium API company and the world's third largest enoxaparin formulation company. The company is a global pharmaceutical company based in China, with global business in the field of heparin sodium preparations and APIs, macromolecule drug CDMO, and innovative drug development. The main products and services include enoxaparin sodium preparations and heparin sodium APIs, enoxaparin sodium APIs, and macromolecule drug CDMO services. Corporate honors: It has successively undertaken national science and technology projects such as the National Biotech Industrialization Demonstration Project, the National Torch Program Project, and the National Key Technological Innovation Project, and has made important contributions to the technological progress, industrial upgrading, and improvement of the ability to generate foreign exchange in China's heparin industry. The company has successively won the “National Technological Innovation Outstanding New Product Award”, “Outstanding Contribution Enterprise to the Shenzhen Special Economic Zone”, “Shenzhen's Outstanding Private Enterprise”, and has become a key high-tech enterprise in the country and Shenzhen.

Company Profile

Symbol09989
Company NameHEPALINK
ISINCNE100003YN2
Listing Date07/08/2020
Issue Price18.40
Shares Offered220.09M share
Founded04/21/1998
RegistrationChina
ChairmanLi Li
SecretaryShiting\qianfengqi Chen
Audit InstitutionErnst & Young (Special General Partnership), Ernst & Young
Company CategoryMainland registration of Mainland Individuals control
Registered OfficeNo. 21, Langshan Road, Songping Mountain, Nanshan District, Shenzhen
Head Office and Principal Place of BusinessRoom 4724, 47th floor, Sun Hung Kai Centre, 30 Harbour Road, Wanchai, Hong Kong
Fiscal Year Ends12-31
Employees2080
MarketHong Kong motherboard
Phone0755-26980311
Fax0755-86142889
Emailstock@hepalink.com
Business Develop, manufacture and sell raw materials (heparin sodium, enoxaparin sodium), and engage in the import and export of goods and technology (excluding distribution and national exclusive, exclusive control, and monopoly products).

Company Executives

  • Name
  • Position
  • Salary
  • Li Li
  • Remuneration Committee Member,Chairman of the Strategic Development Committee,Chairman,Nomination Committee Member,Executive Director
  • 2.96M
  • Tan Li
  • Executive Director,Deputy GM,Member of the Strategic Development Committee
  • 2.42M
  • Yu Dan
  • Executive Director,GM
  • 2.64M
  • Ping Zhang
  • Executive Director
  • --
  • Chuan Lv
  • Nomination Committee Chairman,Member of the Strategic Development Committee,Audit Committee Members,Independent Non-Executive Director
  • 100.00K
  • Peng Huang
  • Chairman of the Audit Committee,Remuneration and Assessment Committee Members,Independent Non-Executive Director
  • --
  • Ming Yi
  • Chairman of the Remuneration and Assessment Committee,Independent Non-Executive Director,Audit Committee Members,Nomination Committee Member
  • --
  • Zehui Zheng
  • Chairman of the Supervisory Board
  • 100.00K
  • Haijun Tang
  • Supervisor
  • 493.00K
  • Jilan Su
  • Employee Representative Supervisor
  • 414.00K
  • Fengqi Qian
  • Authorized Representative,Company Secretary,Joint Company Secretary
  • --
  • Shiting Chen
  • Authorized Representative,Joint Company Secretary
  • --
  • Wenxuan Zhang
  • Securities Affairs Representative
  • --
  • Juan Chen
  • Finance Director
  • --

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
HK
Overall
Symbol
Latest Price
%Chg